{"disease":{"id":"nilotinib","name":"nilotinib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03942094","title":"Nilotinib for First-line Newly Diagnosed CML-CP Patients","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}